| Literature DB >> 19422101 |
Susanna M Hofmann1, Matthias H Tschöp.
Abstract
Coronary heart disease is a major cause of morbidity and mortality in Western societies. The metabolic syndrome, characterized by obesity, insulin resistance, elevated blood pressure, elevated triglycerides, and low levels of high-density lipoprotein cholesterol, confers substantial risk of coronary heart disease. Current pathogenetic models suggest that postprandial hyperlipidemia is one specific metabolic abnormality that is typically associated with increased morbidity. In this issue of the JCI, Stanhope and colleagues demonstrate that consumption of fructose-sweetened but not glucose-sweetened beverages for 10 weeks increases de novo lipid synthesis, promotes dyslipidemia, impairs insulin sensitivity, and increases visceral adiposity in overweight or obese adults (see the related article beginning on page 1322).Entities:
Mesh:
Substances:
Year: 2009 PMID: 19422101 PMCID: PMC2673865 DOI: 10.1172/jci39332
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808